echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > ARD: Use methotrexate to treat rheumatoid arthritis to study whether changes in disease activity can be used as a mediator to reduce cardiovascular risk

    ARD: Use methotrexate to treat rheumatoid arthritis to study whether changes in disease activity can be used as a mediator to reduce cardiovascular risk

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Purpose: Previous studies have shown that the use of methotrexate (MTX) can reduce the risk of atherosclerotic thrombotic cardiovascular disease (CVD) , but its effect on heart failure (HF) and the underlying mechanism of its cardioprotection are known Very little


    Purpose: Previous studies have shown that the use of methotrexate (MTX) can reduce the risk of atherosclerotic thrombotic cardiovascular disease (CVD) , but its effect on heart failure (HF) and the underlying mechanism of its cardioprotection are known Very little






    Source:

    Johnson TM, Sayles HR, Baker JF , et al .


    Johnson TM, Sayles HR, Baker JF , et al .




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.